Fresenius Medical Care AG FMS
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.51% | 4.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.51% | 4.76% | |||
| Cost of Revenue | 2.05% | 2.82% | |||
| Gross Profit | -3.65% | 10.41% | |||
| SG&A Expenses | -0.02% | -2.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 37.74% | -36.20% | |||
| Total Operating Expenses | 1.80% | 1.76% | |||
| Operating Income | -10.14% | 38.60% | |||
| Income Before Tax | -21.80% | 83.47% | |||
| Income Tax Expenses | -14.25% | 108.87% | |||
| Earnings from Continuing Operations | -24.12% | 76.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 13.97% | -57.41% | |||
| Net Income | -27.59% | 84.71% | |||
| EBIT | -10.14% | 38.60% | |||
| EBITDA | -6.62% | 20.11% | |||
| EPS Basic | -26.08% | 89.39% | |||
| Normalized Basic EPS | 8.90% | 10.08% | |||
| EPS Diluted | -25.76% | 88.57% | |||
| Normalized Diluted EPS | 8.90% | 10.08% | |||
| Average Basic Shares Outstanding | -2.04% | -2.47% | |||
| Average Diluted Shares Outstanding | -2.04% | -2.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.00% | -- | |||